Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: A 48-month follow-up
Ana Domingos, Joana Vidinha, Rui Osório and 5 more
Nefrología (English Edition) · 2021
doi:10.1016/j.nefroe.2021.04.004 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Dear Editor, Amyloidosis represents a family of diseases characterized by the deposition of proteinaceous material in the extracellular space that, by forming insoluble clusters on various tissues and organs, affects its function.
Abstract licence: CC BY-NC-ND
References3
3 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.